Tenet Reports Results for the Second Quarter Ended June 30, 2017
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Tenet Healthcare (THC) PT Lowered to $24 at Jefferies
August 8, 2017 8:21 AM EDTJefferies lowered its price target on Tenet Healthcare (NYSE: THC) to $24.00 (from $26.00) while maintaining a Buy rating. While THC's Q2 results came in slightly below consensus, analyst Brian Tanquilut views the revenue and EBITDA shortfalls as modest relative to expectations baked into the... More
